Video NET With CYP Who Witnessed Domestic Violence
Launched by UNIVERSITY OF NOTTINGHAM · Apr 28, 2021
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
The purpose of the study is to investigate the potential effectiveness, feasibility, acceptability and putative mechanisms of change of video NET with children and young people who witnessed domestic violence.
The primary objective of the study is to evaluate whether video NET can reduce PTS in this group.
The secondary objectives of the study are:
* To determine whether video NET can also impact on general psychological distress and functioning;
* To examine the putative mechanisms of change within NET, i.e. habituation and integration of trauma memories;
* To explore the feasibility an...
Gender
ALL
Eligibility criteria
- Inclusion Criteria - Participants must:
- • Be aged 12- 17;
- • Have witnessed domestic violence in the past;
- • Be experiencing clinical levels of post-traumatic stress, as assessed by a member of the CAMHS team;
- • Be on the waiting list to receive trauma-focused treatment;
- • If 16 or over, be able to consent to take part, as assessed by a member of the CAMHS team;
- • If under 16, have at least one person with parental authority who can consent for them. These young people will also be asked to provide their assent;
- • Be able to communicate verbally and speak English;
- • Have access to a device with a webcam and Internet broadband to enable participation in video sessions;
- • Have access to a mobile device, e.g. a smartphone or a tablet. Can be the same as the device above.
- Exclusion Criteria - Participants will be excluded from the study if:
- • They have a known diagnosis of Intellectual Disability;
- • They have a current high level of risk including of self-harm, suicide or current exposure to domestic violence, as assessed by a member of the CAMHS team;
- • They are substance dependent.
About University Of Nottingham
The University of Nottingham is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university harnesses cutting-edge research and expert faculty to address pressing medical challenges. Through its dedicated clinical trials unit, the University of Nottingham conducts rigorous studies aimed at improving patient outcomes and contributing to the global body of medical knowledge. The institution prioritizes ethical practices and participant safety, ensuring that all trials are designed to uphold the highest standards of scientific integrity and regulatory compliance.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lincoln, , United Kingdom
Nottingham, Nottinghamshire, United Kingdom
Lincoln, Lincolnshire, United Kingdom
Patients applied
Trial Officials
Thomas Schröder, PhD
Study Director
University of Nottingham
Sarah Wilde, DClinPsy
Study Director
University of Lincoln
Fiammetta Rocca, Trainee Clinical Psychologist, MSc
Principal Investigator
University of Nottingham
Nima Moghaddam, PhD, DClinPsy
Study Director
University of Lincoln
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials